1. Siddik ZH, Jones MR, Boxall FE, Harrap KR (1988) Comparative distribution and excretion of carboplatin and cisplatin in mice. Cancer Chemother Pharmacol 21:19?24
2. Kelland LR, Jones M, Gwynne JJ, Valenti M, Murrer BA, Barnard CFJ, Vollano JF, Giandomenico CM, Abrams MJ, Harrap KR (1993) Antitumour activity of orally administered ammine/amine platinum(IV) dicarboxylate complexes against a panel of human ovarian carcinoma xenografts. Int J Oncol 2:1043?1048
3. Harrap KR, Murrer BA, Giandomenico C, Morgan SE, Kelland LR, Jones M, Goddard PM, Schurig J (1991) Ammine/amine platinum IV platinum dicarboxylates: a novel class of complexes which circumvent intrinsic cisplatin resistance. In: Howell SB (ed) Platinum and other metal coordination compounds in cancer chemotherapy. Plenum, New York, pp 391?399
4. Kelland LR, Murrer BA, Abel G, Giandmenico CM, Mistry P, Harrap KR (1992) Ammine/amine platinum(IV) dicarboxylate complexes: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically resistant human ovarian carcinoma cells. Cancer Res 52:822?828
5. Kelland LR, Abel G, McKeage MJ, Jones M, Goddard PM, Valenti M, Murrer BA, Harrap KR (1993) Preclinical antitumour evaluation of bis-acetato-amine-dichloro-cyclohexylamine platinum(IV): an orally active platinum drug. Cancer Res 53: 2581?2586